Spreading easily through the air, Mycobacterium tuberculosis can establish a chronic infection in human lungs, which can turn ...

Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...

As it happens, Mycobacterium tuberculosis, the bacteria that causes tuberculosis, is second only to SARS-CoV-2 as the leading cause of death by infection right now. And it’s on the rise ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

In a concerning development, two female elephants at Karachi’s Safari Park, Malaika and Madhubala, have been diagnosed with ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Seventeen Oxford University researchers have been awarded £5 million to develop new therapies for drug-resistant tuberculosis ...

Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. While multidrug treatment regimens are the standard of care, the lengthy treatment schedule and ...